dermanostic has secured €4 million in Pre-Series A funding led by DvH Ventures to expand its digital dermatology services across Europe.

Target Information

dermanostic is a prominent telemedicine provider specializing in digital dermatology in Germany. The platform offers an innovative approach that allows patients to submit photos and a brief medical questionnaire through its application, receiving a specialist diagnosis rapidly—often within hours. This service includes prescription options when necessary, all while ensuring high medical standards through a model supported by over 20 board-certified dermatologists.

As one of Germany's leading digital dermatology platforms, dermanostic's mission is to enhance the efficiency and accessibility of dermatological care. Its unique asynchronous treatment model ensures that patients can swiftly access expert medical opinions, thus addressing the growing demand for remote healthcare solutions.

Industry Overview in Germany

The digital healthcare industry in Germany has shown remarkable growth, driven by an increasing need for accessible healthcare services and the ongoing digital transformatio

View Source

Similar Deals

High-Tech Gründerfonds Sedivention

2024

Pre-Seed Stage Proprietary & Advanced Pharmaceuticals Germany
BONVENTURE caera

2023

Pre-Seed Stage Medical Software & Technology Services Germany
Convergence Partners neotiv GmbH

2022

Pre-Seed Stage Medical & Diagnostic Laboratories Germany
Leica Microsystems ATTO-TEC

2025

Buyout Biotechnology & Medical Research (NEC) Germany

Dieter von Holtzbrinck Ventures

invested in

dermanostic

in 2025

in a Pre-Seed Stage deal

Disclosed details

Transaction Size: $4M

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert